204 related articles for article (PubMed ID: 18383004)
1. Allergic contact dermatitis to topical drugs--epidemiological risk assessment.
de Pádua CA; Schnuch A; Nink K; Pfahlberg A; Uter W
Pharmacoepidemiol Drug Saf; 2008 Aug; 17(8):813-21. PubMed ID: 18383004
[TBL] [Abstract][Full Text] [Related]
2. Contact allergy to topical drugs: prevalence in a clinical setting and estimation of frequency at the population level.
de Pádua CA; Uter W; Schnuch A
Pharmacoepidemiol Drug Saf; 2007 Apr; 16(4):377-84. PubMed ID: 16981214
[TBL] [Abstract][Full Text] [Related]
3. Contact allergy to topical corticosteroids--results from the IVDK and epidemiological risk assessment.
Uter W; de Pádua CM; Pfahlberg A; Nink K; Schnuch A; Lessmann H
J Dtsch Dermatol Ges; 2009 Jan; 7(1):34-41, 34-42. PubMed ID: 18761609
[TBL] [Abstract][Full Text] [Related]
4. [Contact allergy to topical ophthalmological drugs - epidemiological risk assessment].
Uter W; Menezes de Pádua C; Pfahlberg A; Nink K; Schnuch A; Behrens-Baumann W
Klin Monbl Augenheilkd; 2009 Jan; 226(1):48-53. PubMed ID: 19173163
[TBL] [Abstract][Full Text] [Related]
5. [A common and insidious side-effect: allergic contact dermatitis caused by bufexamac used in the treatment of dermatitis. Results from the Information Network of Departments of Dermatology (IDVK)].
Schnuch A; Gefeller O; Uter W
Dtsch Med Wochenschr; 2005 Dec; 130(50):2881-6. PubMed ID: 16342011
[TBL] [Abstract][Full Text] [Related]
6. Contact allergy to neomycin sulfate: results of a multifactorial analysis.
Menezes de Pádua CA; Schnuch A; Lessmann H; Geier J; Pfahlberg A; Uter W
Pharmacoepidemiol Drug Saf; 2005 Oct; 14(10):725-33. PubMed ID: 15880442
[TBL] [Abstract][Full Text] [Related]
7. [Anogenital dermatoses--allergic and irritative causative factors. Analysis of IVDK data and review of the literature].
Kügler K; Brinkmeier T; Frosch PJ; Uter W
J Dtsch Dermatol Ges; 2005 Dec; 3(12):979-86. PubMed ID: 16405714
[TBL] [Abstract][Full Text] [Related]
8. Prevalence and risk factors for allergic contact dermatitis to topical treatment in atopic dermatitis: a study in 641 children.
Mailhol C; Lauwers-Cances V; Rancé F; Paul C; Giordano-Labadie F
Allergy; 2009 May; 64(5):801-6. PubMed ID: 19183418
[TBL] [Abstract][Full Text] [Related]
9. Acceptable risk of contact allergy in the general population assessed by CE-DUR--a method to detect and categorize contact allergy epidemics based on patient data.
Thyssen JP; Menné T; Schnuch A; Uter W; White I; White JM; Johansen JD
Regul Toxicol Pharmacol; 2009 Jul; 54(2):183-7. PubMed ID: 19383524
[TBL] [Abstract][Full Text] [Related]
10. Periorbital dermatitis--a recalcitrant disease: causes and differential diagnoses.
Feser A; Plaza T; Vogelgsang L; Mahler V
Br J Dermatol; 2008 Sep; 159(4):858-63. PubMed ID: 18721191
[TBL] [Abstract][Full Text] [Related]
11. Unusual patterns in contact dermatitis: medicaments.
Davis MD
Dermatol Clin; 2009 Jul; 27(3):289-97, vi. PubMed ID: 19580923
[TBL] [Abstract][Full Text] [Related]
12. Epidemiology of contact allergy: an estimation of morbidity employing the clinical epidemiology and drug-utilization research (CE-DUR) approach.
Schnuch A; Uter W; Geier J; Gefeller O;
Contact Dermatitis; 2002 Jul; 47(1):32-9. PubMed ID: 12225411
[TBL] [Abstract][Full Text] [Related]
13. Allergic contact dermatitis due to beta-blockers in eye drops: a retrospective analysis of multicentre surveillance data 1993-2004.
Jappe U; Uter W; Menezes de Pádua CA; Herbst RA; Schnuch A
Acta Derm Venereol; 2006; 86(6):509-14. PubMed ID: 17106597
[TBL] [Abstract][Full Text] [Related]
14. Contact allergy to hairdressing allergens in female hairdressers and clients--current data from the IVDK, 2003-2006.
Uter W; Lessmann H; Geier J; Schnuch A
J Dtsch Dermatol Ges; 2007 Nov; 5(11):993-1001. PubMed ID: 17976140
[TBL] [Abstract][Full Text] [Related]
15. Sources of sensitization, cross-reactions, and occupational sensitization to topical anaesthetics among general dermatology patients.
Jussi L; Lammintausta K
Contact Dermatitis; 2009 Mar; 60(3):150-4. PubMed ID: 19260912
[TBL] [Abstract][Full Text] [Related]
16. Detection of contact hypersensitivity to corticosteroids in allergic contact dermatitis patients who do not respond to topical corticosteroids.
Gönül M; Gül U
Contact Dermatitis; 2005 Aug; 53(2):67-70. PubMed ID: 16033397
[TBL] [Abstract][Full Text] [Related]
17. A further characteristic of susceptibility to contact allergy: sensitization to a weak contact allergen is associated with polysensitization. Results of the IVDK.
Schnuch A; Brasch J; Lessmann H; Geier J; Uter W
Contact Dermatitis; 2007 Jun; 56(6):331-7. PubMed ID: 17577374
[TBL] [Abstract][Full Text] [Related]
18. Contact allergy to topical medicaments becomes more common with advancing age: an age-stratified study.
Green CM; Holden CR; Gawkrodger DJ
Contact Dermatitis; 2007 Apr; 56(4):229-31. PubMed ID: 17343625
[TBL] [Abstract][Full Text] [Related]
19. The prevalence of contact allergy differed between population-based and clinic-based data.
Uter W; Ludwig A; Balda BR; Schnuch A; Pfahlberg A; Schäfer T; Wichmann HE; Ring J
J Clin Epidemiol; 2004 Jun; 57(6):627-32. PubMed ID: 15246132
[TBL] [Abstract][Full Text] [Related]
20. [Severe allergic contact dermatitis with generalized spread due to bufexamac presenting as the "baboon" syndrome].
Proske S; Uter W; Schnuch A; Hartschuh W
Dtsch Med Wochenschr; 2003 Mar; 128(11):545-7. PubMed ID: 12635026
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
